236 related articles for article (PubMed ID: 17643185)
1. Successful use of infliximab in the treatment of Reiter's syndrome: a case report and discussion.
Gill H; Majithia V
Clin Rheumatol; 2008 Jan; 27(1):121-3. PubMed ID: 17643185
[TBL] [Abstract][Full Text] [Related]
2. Infliximab in the treatment of an HIV positive patient with Reiter's syndrome.
Gaylis N
J Rheumatol; 2003 Feb; 30(2):407-11. PubMed ID: 12563704
[TBL] [Abstract][Full Text] [Related]
3. Successful use of etanercept for the treatment of Reiter's syndrome: a case report and review of the literature.
Edrees A
Rheumatol Int; 2012 Jan; 32(1):1-3. PubMed ID: 21785961
[TBL] [Abstract][Full Text] [Related]
4. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
[TBL] [Abstract][Full Text] [Related]
5. Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors.
Kita J; Tamai M; Arima K; Nakashima Y; Suzuki T; Kawashiri SY; Okada A; Koga T; Yamasaki S; Nakamura H; Origuchi T; Aramaki T; Nakashima M; Fujikawa K; Tsukada T; Ida H; Aoyagi K; Uetani M; Eguchi K; Kawakami A
Mod Rheumatol; 2012 Apr; 22(2):195-201. PubMed ID: 21898075
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of severe Reiter's syndrome associated with human immunodeficiency virus infection with etretinate. Report of 2 cases.
Louthrenoo W
J Rheumatol; 1993 Jul; 20(7):1243-6. PubMed ID: 8371230
[TBL] [Abstract][Full Text] [Related]
7. An acute remission of Reiter's syndrome in male patients treated with bromocriptine.
Bravo G; Zazueta B; Lavalle C
J Rheumatol; 1992 May; 19(5):747-50. PubMed ID: 1351943
[TBL] [Abstract][Full Text] [Related]
8. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection.
Schafranski MD
Rheumatol Int; 2010 Mar; 30(5):679-80. PubMed ID: 19466419
[TBL] [Abstract][Full Text] [Related]
9. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.
Lipsky PE; van der Heijde DM; St Clair EW; Furst DE; Breedveld FC; Kalden JR; Smolen JS; Weisman M; Emery P; Feldmann M; Harriman GR; Maini RN;
N Engl J Med; 2000 Nov; 343(22):1594-602. PubMed ID: 11096166
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy.
Tse SM; Burgos-Vargas R; Laxer RM
Arthritis Rheum; 2005 Jul; 52(7):2103-8. PubMed ID: 15986366
[TBL] [Abstract][Full Text] [Related]
11. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis.
Antoni C; Kalden JR
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S73-7. PubMed ID: 10589362
[TBL] [Abstract][Full Text] [Related]
13. AIDS-associated Reiter's syndrome.
Altman EM; Centeno LV; Mahal M; Bielory L
Ann Allergy; 1994 Apr; 72(4):307-16. PubMed ID: 8154628
[TBL] [Abstract][Full Text] [Related]
14. [Reiter's syndrome exacerbated by indomethacin].
Allegue F; Boixeda P; España A; Moreno R; Ledo A
Med Cutan Ibero Lat Am; 1989; 17(2):113-6. PubMed ID: 2666796
[TBL] [Abstract][Full Text] [Related]
15. A Case Study on Successful Ayurvedic Management of a Rare Case of Reiter's Syndrome.
Kuchewar V
Anc Sci Life; 2017; 36(4):225-228. PubMed ID: 29269976
[TBL] [Abstract][Full Text] [Related]
16. Clinical synovitis in a particular joint is associated with progression of erosions and joint space narrowing in that same joint, but not in patients initially treated with infliximab.
Klarenbeek NB; Güler-Yüksel M; van der Heijde DM; Hulsmans HM; Kerstens PJ; Molenaar TH; de Sonnaville PB; Huizinga TW; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2010 Dec; 69(12):2107-13. PubMed ID: 20610442
[TBL] [Abstract][Full Text] [Related]
17. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Bendtzen K; Geborek P; Svenson M; Larsson L; Kapetanovic MC; Saxne T
Arthritis Rheum; 2006 Dec; 54(12):3782-9. PubMed ID: 17133559
[TBL] [Abstract][Full Text] [Related]
18. Early rheumatoid arthritis in a patient with Sjögren's syndrome and pulmonary nodular amyloidosis: clinical implication of early limited use of infliximab.
Mori S; Koga Y; Imamura F; Cho I; Sugimoto M
Mod Rheumatol; 2007; 17(6):500-6. PubMed ID: 18084704
[TBL] [Abstract][Full Text] [Related]
19. Infliximab for psoriasis and psoriatic arthritis.
Antoni C; Manger B
Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S122-5. PubMed ID: 12463461
[TBL] [Abstract][Full Text] [Related]
20. Modification of pro- and antiinflammatory cytokines and vascular-related molecules by tumor necrosis factor-a blockade in patients with rheumatoid arthritis.
Macías I; García-Pérez S; Ruiz-Tudela M; Medina F; Chozas N; Girón-González JA
J Rheumatol; 2005 Nov; 32(11):2102-8. PubMed ID: 16265686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
